Table 2. . Nanostructured lipid carriers fabricated using emulsification and low-temperature solidification technique.
Active ingredient | Solid lipid | Liquid lipid | Surfactants | Size (nm) | Research highlights | Ref. |
---|---|---|---|---|---|---|
Baicalin |
Glycerol monostearate |
Medium chain triglyceride |
Soya lecithin |
244.7 |
1.9-fold improvement in AUC and 1.7-fold improvement in mean residence time in case of drug-loaded NLCs in comparison to drug suspension |
[23] |
Biochanin A |
Glycerol monostearate |
Medium chain triglyceride |
Soya lecithin, Tween 80 |
148.5 ± 2.88 |
Higher AUC value of drug-loaded PEGylated NLCs in comparison to drug suspension Biochanin-loaded PEGylated NLCs showed higher in vitro cytotoxicity against MCF-7 cell line compared with drug suspension |
[25] |
Etoposide |
Glyceryl monostearate |
Soyabean oil |
Soya lecithin |
91.2–125.9 |
Higher cytotoxicity of drug-loaded NLCs against human epithelial-like lung carcinoma cell |
[26] |
Silymarin | Glycerol monostearate | Oleic acid | Tween 80 | 223.73 ± 43.39 | In vivo study revealed high accumulation of drug in liver after encapsulation in NLCs | [15] |
AUC: Area under curve; NLC: Nanostructured lipid carrier.